A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

Author:

Kast Richard E.1,Boockvar John A.2,Brüning Ansgar3,Cappello Francesco4,Chang Wen-Wei5,Cvek Boris6,Dou Q. Ping7,Duenas-Gonzalez Alfonso8,Efferth Thomas9,Focosi Daniele10,Ghaffari Seyed H.11,Karpel-Massler Georg12,Ketola Kirsi13,Khoshnevisan Alireza14,Keizman Daniel15,Magné Nicolas16,Marosi Christine17,McDonald Kerrie18,Muñoz Miguel19,Paranjpe Ameya20,Pourgholami Mohammad H.18,Sardi Iacopo21,Sella Avishay22,Srivenugopal Kalkunte S.20,Tuccori Marco10,Wang Weiguang23,Wirtz Christian R.12,Halatsch Marc-Eric12

Affiliation:

1. IIAIGC Headquarters, Dean of Studies, Burlington, VT, USA

2. Weill Cornell Medical College, NY, USA

3. University of München, München, Germany

4. University of Palermo, Palermo, Italy

5. Chung Shan Medical University Hospital, Taichung, Taiwan

6. Palacky University, Olomouc, Czech Republic

7. Wayne State University, Detroit, USA

8. Instituto de Investigaciones Biomedicas UNAM, Instituto Nacional de Cancerología, Mexico City, Mexico

9. Johannes Gutenberg University, Mainz, Germany

10. University of Pisa, Pisa, Italy

11. Tehran University of Medical Sciences, Tehran, Iran

12. University of Ulm, Ulm, Germany

13. University of British Columbia, Vancouver, Canada

14. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

15. Oncology Department, Meir Medical Center, Tel Aviv University, Israel

16. Institut de Cancérologie Lucien Neuwirth, Saint-Priest en Jarez, France

17. Medical University of Vienna, Wein, Austria

18. University of New South Wales, Sydney, Australia

19. Virgen del Rocío University Hospital, Sevilla, Spain

20. Texas Tech University Health Sciences Center, Amarillo, USA

21. Meyer Children's Hospital, Firenze, Italy

22. Assaf Harofeh Medical Center, Zerifin, Israel

23. University of Wolverhampton, Wolverhampton, UK

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3